Laurion Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-11,504
| Closed | -$887K | – | 368 |
|
2022
Q1 | $887K | Buy |
+11,504
| New | +$887K | 0.01% | 148 |
|
2021
Q3 | – | Sell |
-379,356
| Closed | -$31.7M | – | 447 |
|
2021
Q2 | $31.7M | Buy |
379,356
+3,484
| +0.9% | +$291K | 0.18% | 30 |
|
2021
Q1 | $28.4M | Buy |
375,872
+363,899
| +3,039% | +$27.5M | 0.15% | 59 |
|
2020
Q4 | $1.05M | Buy |
+11,973
| New | +$1.05M | 0.01% | 214 |
|
2019
Q4 | – | Sell |
-40,066
| Closed | -$2.7M | – | 521 |
|
2019
Q3 | $2.7M | Buy |
+40,066
| New | +$2.7M | 0.02% | 130 |
|
2018
Q4 | – | Sell |
-266
| Closed | -$26K | – | 716 |
|
2018
Q3 | $26K | Buy |
+266
| New | +$26K | ﹤0.01% | 726 |
|